Working in collaboration with our customers, we have gained extensive experience in the determination of Aerodynamic Particle Size Distribution (APSD) and Delivered Dose (DD) for Dry Powder Inhalers (DPI) and Metered Dose Inhalers (MDI), as well as the droplet size distribution for nasal sprays. The generic methods based on to the Anderson Cascade Impactors and Next Generation Impactors, and can be adapted to your product or transferred in to our special laboratory.
This complex and time-consuming analysis is well suited for external contracting, as it would otherwise tie up extensive headcount and instrumental capacities of the customer. Our existing customers value the use of these services within stability studies and as supporting analytics for drug/device development.
More about inhalative analytics